Medications

FDA approves first liquid, nonstimulant ADHD treatment

The U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).

Diseases, Conditions, Syndromes

Ticks and the diseases they carry

In many regions of the U.S. and the world, enjoying the great outdoors comes with a hidden risk: ticks and the diseases they carry. Ticks can carry pathogens like Borrelia burgdorferi and Borrelia mayonii, which can cause ...

page 1 from 40